N-Desmethyl Imatinib is primarily used in research and clinical studies as a metabolite of Imatinib, a well-known tyrosine kinase inhibitor. Its applications are largely focused on understanding the pharmacokinetics and metabolic pathways of Imatinib, which is used to treat certain types of cancer, such as chronic myeloid leukemia (CML) and gastrointestinal stromal tumors (GIST). By studying N-Desmethyl Imatinib, researchers can gain insights into how the body processes Imatinib, including its efficacy, potential side effects, and interactions with other drugs. This information is crucial for optimizing dosing regimens and improving therapeutic outcomes for patients. Additionally, N-Desmethyl Imatinib may be used in the development of new analytical methods for monitoring drug levels in patients undergoing treatment with Imatinib.